Offer - Urjas Oil for just ₹ 1
Unimika 500 Injection is a prescription drug, available for use as Injection. It is primarily used for the treatment of Urinary Tract Infection. Other than this, Unimika 500 Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Unimika 500 Injection is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Unimika 500 Injection side effects, there are can be others also. These have been listed below. Such side effects of Unimika 500 Injection normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Unimika 500 Injection's effect is Severe during pregnancy and Unknown for lactating mothers. Further, the section on Unimika 500 Injection related warnings talks about Unimika 500 Injection's effects on the liver, heart and kidney.
Unimika 500 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Unimika 500 Injection in conditions like Dehydration, Parkinson's Disease, Hearing Loss. Some other conditions that can be affected by Unimika 500 Injection are listed in the contraindications section below.
Besides this, Unimika 500 Injection may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Unimika 500 Injection is considered safe while driving, and is addictive.
Unimika 500 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 2 - 12 years (Child) |
|
Is the use of Unimika 500 Injection safe for pregnant women?
Unimika has many dangerous side effects in pregnant women. If you are pregnant, do not consume Unimika without medical advice.
Is the use of Unimika 500 Injection safe during breastfeeding?
No research work has been carried out till date on effect of Unimika on breastfeeding women. So it is not known whether taking Unimika will cause side effects or not.
What is the effect of Unimika 500 Injection on the Kidneys?
Use of Unimika may be dangerous for kidney. Do not use it without doctor advice.
What is the effect of Unimika 500 Injection on the Liver?
Side effects of Unimika rarely affect the liver.
What is the effect of Unimika 500 Injection on the Heart?
Unimika may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Unimika 500 Injection unless your doctor advises you to do so -
Is this Unimika 500 Injection habit forming or addictive?
No, you will not get addicted to Unimika 500 Injection.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Unimika 500 Injection as it does not make you drowsy.
Is it safe?
Yes, but take Unimika 500 Injection only as per medical advice.
Is it able to treat mental disorders?
No, the use of Unimika 500 Injection in mental disorders is not effective.
Interaction between Food and Unimika 500 Injection
You can take Unimika 500 Injection with food.
Interaction between Alcohol and Unimika 500 Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Unimika 500 Injection with alcohol will be.
No, Unimika cannot be taken with penicillin. Because penicillin inactivates the Unimika by combining the beta-lactam ring of penicillin with an amino group of this drug to form amide which is biologically inactive. For this reason Unimika should not be taken with penicillin. The chances of inactivation of this drug are higher in case of renal failure because in this case concentration of penicillin is higher in the kidney for a longer time as compared to the normal renal function.
Occasionally, Unimika can cause drug-induced thrombocytopenia (blood clot formation in the vessel). However, if you experience severe thrombocytopenia after taking this medicine, please immediately seek medical help.
Yes, Unimika is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as decreased urination, itching, irritation, and hearing loss. If you experience above-mentioned side after consuming this medicine then inform your doctor and follow his/her instructions.
Unimika is a brand name for amikacin. It is a prescription drug which belongs to the class of medication known as an aminoglycoside antibiotic. It is a broad spectrum antibiotic which is used for the treatment of bacterial infection such as bone, joint, skin, intra-abdominal, pneumonia, and respiratory tract infection. It is used for short-term treatment (7 - 10 days) of bacterial infection in different part of the body. It is also used for the treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.
Yes, Unimika is effective against bacteria (Pseudomonas). But it is also found that Pseudomonas can get resistant to this drug and in that case Unimika will not produce desired results. If you are experiencing no symptomatic relief after taking this medicine then inform your doctor and follow his/her instructions.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
